Exxua, a Novel Treatment for Major Depressive Disorder, Gets FDA Approval
The FDA has approved Exxua (gepirone HCl extended-release tablets) for the treatment of major depressive disorder in adults.
Source: empr.com
📰 Boxed Warning News
Page 18 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
FDA Approves Gepirone Hydrochloride Tablets for Major Depression
The indication is the first for an antidepressant that selectively targets the serotonin 1A receptor—a regulator of mood and emotion.
United States Stephen Stahl Anitah Clayton Fabre Kramer Pharmaceuticals University Of California Drug Administration
Source: hcplive.com
Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and...
Source: prnewswire.com
Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems, Inc. (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, in the form of a total of 86,000 shares...
Source: lelezard.com
Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of OnabotulinumtoxinA (BOTOX® Cosmetic) for the Treatment of Platysma Prominence
/PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from the second of three Phase 3 clinical studies...
Source: prnewswire.com
Intra-Cellular Therapies Announces Presentations at Psych Congress 2023 Including Positive ...
NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders,
Cameron Radinovic Juan Sanchez Roger Mcintyre Suresh Durgam University Of Toronto Exchange Commission
Source: eagletribune.com
Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the presentation of multiple posters highlighting real-world and clinical data at the 36th Annual...
United States Marisa Borgasano Sandy Coombs Aripiprazole Lauroxil Craig Hopkinson Research Development At Alkermes
Source: prnewswire.com
Jazz Pharmaceuticals Showcases Impact of Sleep Medicine Portfolio at Psych Congress 2023
/PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that six abstracts presenting data from across its sleep medicine portfolio were...
Source: prnewswire.com
Supernus Announces New Qelbree® Data Showing Improvement in
Topline results from Phase IV study demonstrate Qelbree is safe and well-tolerated, and significantly improved efficacy outcomes when added to a stimulant...
Source: globenewswire.com
Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms
Topline results from Phase IV study demonstrate Qelbree is safe and well-tolerated, and significantly improved efficacy outcomes when added to a stimulant medication in pediatric patients with...
Source: marketscreener.com